COVID-19

Rainha Passi1, Justyna Cholewa-Waclaw2, Ryan Wereski3

  • 1BHF Centre for Cardiovascular Science, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, and VIB Centre for Cancer Biology, VIB, Leuven, Belgium.

Vascular pharmacology
|January 24, 2024
PubMed
概括

严重的COVID-19会改变肺微血管 (pMV) 内皮细胞,导致功能衰退和形态变化. 鉴定出来的基因可能是治疗干预的目标,以恢复内皮健康.